Personal information

Belgium

Activities

Employment (2)

KU Leuven - Biomedical Quality Assurance Research Unit: Leuven, Vlaams-Brabant, BE

2015-09-14 to present | PhD (Public Health & Primary Care)
Employment
Source: Self-asserted source
Cleo Keppens

KU Leuven - Biomedical Quality Assurance Research Unit: Leuven, Vlaams-Brabant, BE

2014-09-15 to present | EQA scheme coordinator (Public Health & Primary Care)
Employment
Source: Self-asserted source
Cleo Keppens

Works (41)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect

Virchows Archiv
2021-08-08 | Journal article
Contributors: Cleo Keppens; Elke Boone; Paula Gameiro; Véronique Tack; Elisabeth Moreau; Elizabeth Hodges; Paul Evans; Monika Brüggemann; Ian Carter; Dido Lenze et al.
Source: check_circle
Crossref

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys

Virchows Archiv
2021-05-23 | Journal article
Contributors: Cleo Keppens; Ed Schuuring; Elisabeth M. C. Dequeker
Source: check_circle
Crossref

PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation

Virchows Archiv
2021-05-04 | Journal article
Contributors: Cleo Keppens; Elisabeth MC Dequeker; Patrick Pauwels; Ales Ryska; Nils ‘t Hart; Jan H von der Thüsen
Source: check_circle
Crossref

Incidents in Molecular Pathology: Frequency and Causes During Routine Testing

Arch Pathol Lab Med
2021-01-07 | Journal article
Source: Self-asserted source
Cleo Keppens

Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples

BMC Cancer
2020-12 | Journal article
Contributors: Cleo Keppens; Elisabeth M. C. Dequeker; Etienne Rouleau; Nils ’t Hart; Lukas Bubendorf; Kelly Dufraing; Céline Garrec; Paul Guéguen; Aude Lamy; Antonio Marchetti et al.
Source: check_circle
Crossref

Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non–Small-Cell Lung Cancer

The Journal of Molecular Diagnostics
2020-12 | Journal article
Contributors: Cleo Keppens; Jan von der Thüsen; Patrick Pauwels; Ales Ryska; Nils ’t Hart; Ed Schuuring; Keith Miller; Erik Thunnissen; Karen Zwaenepoel; Elisabeth M.C. Dequeker
Source: check_circle
Crossref

Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers

Diagnostics
2020-10-18 | Journal article
Contributors: Cleo Keppens; Ed Schuuring; Elisabeth MC Dequeker
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Quality improvement tools for predictive testing in pathology.

2020-08-28 | Dissertation or Thesis
Source: Self-asserted source
Cleo Keppens

Implementation of Novel Methods, Markers or Sample types in Molecular Pathology – Quality Assurance Aspects

Archives of Clinical and Biomedical Research
2020-07-23 | Journal article
Part of ISSN: 2572-5017
Source: Self-asserted source
Cleo Keppens

External Quality Assessment Schemes for Biomarker Testing in Oncology

The Journal of Molecular Diagnostics
2020-06 | Journal article
Contributors: Kaat Van Casteren; Cleo Keppens; Ed Schuuring; Zandra C. Deans; Nicola Normanno; Simon J. Patton; Elisabeth M.C. Dequeker
Source: check_circle
Crossref

Evolution of RAS testing over time: factors influencing mutation rates in metastatic colorectal cancer patients

Colorectal Cancer
2020-01-27 | Journal article
Part of ISSN: 1758-194X
Part of ISSN: 1758-1958
Source: Self-asserted source
Cleo Keppens

Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?

Human Mutation
2020-01-14 | Journal article
Contributors: Cleo Keppens; Véronique Tack; Kelly Dufraing; Etienne Rouleau; Marjolijn J. L. Ligtenberg; Ed Schuuring; Elisabeth M. C. Dequeker
Source: check_circle
Crossref

Findings from the global external quality assessment of lung cancer liquid biopsy testing.

The Journal of Molecular Diagnostics
2019-11 | Conference abstract
Part of ISSN: 1525-1578
Source: Self-asserted source
Cleo Keppens

Two years of BRCA1 and BRCA2 somatic external quality assessment with Gen&Tiss scheme in France

Annals of Oncology
2019-10 | Journal article
Part of ISSN: 0923-7534
Source: Self-asserted source
Cleo Keppens

Results of a global external quality assessment scheme for EGFR testing on liquid biopsy.

ESMO
2019-09-27 | Conference poster
Source: Self-asserted source
Cleo Keppens

Global delivery of external quality assessment for lung cancer liquid biopsy testing.

the 31st European Congress of Pathology - Two-Day Molecular Pathology Diagnostics Symposium
2019-09-07 | Conference poster
Source: Self-asserted source
Cleo Keppens

Pre-Analytical Challenges during RAS Testing: Tissue Quality and the Estimation of Neoplastic Cell Percentage

Biomarkers Journal
2019-07-26 | Journal article
Source: Self-asserted source
Cleo Keppens

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.

Virchows Archiv : an international journal of pathology
2019-04-26 | Journal article
Source: Self-asserted source
Cleo Keppens

European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.

Virchows Archiv : an international journal of pathology
2019-02-05 | Journal article
Source: Self-asserted source
Cleo Keppens

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA

BMC Cancer
2018-12 | Journal article
Contributors: Cleo Keppens; Elisabeth M. C. Dequeker; Simon J. Patton; Nicola Normanno; Francesca Fenizia; Rachel Butler; Melanie Cheetham; Jennifer A. Fairley; Hannah Williams; Jacqueline A. Hall et al.
Source: check_circle
Crossref

Describing the Reportable Range Is Important for Reliable Treatment Decisions

The Journal of Molecular Diagnostics
2018-11 | Journal article
Contributors: Véronique Tack; Lien Spans; Ed Schuuring; Cleo Keppens; Karen Zwaenepoel; Patrick Pauwels; Jeroen Van Houdt; Elisabeth M.C. Dequeker
Source: check_circle
Crossref

Predictive biomarker analysis in NSCLC

The Official European Hospital and Healthcare Federation Reference Book
2018-10-02 | Interactive resource
Source: Self-asserted source
Cleo Keppens

Adopting HGVS recommendations for reporting of biomarker results: where are we now?

the 30th European Congress of Pathology
2018-09-08 | Conference poster
Source: Self-asserted source
Cleo Keppens

Implementation of novel methods, markers or sample types in molecular pathology – quality assurance aspects.

the 30th European Congress of Pathology
2018-09-08 | Conference poster
Source: Self-asserted source
Cleo Keppens

Longitudinal analysis of error causes and follow-up in external quality assessment schemes.

the 30th European Congress of Pathology
2018-09-08 | Conference poster
Source: Self-asserted source
Cleo Keppens

Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.

British journal of cancer
2018-08-24 | Journal article
Source: Self-asserted source
Cleo Keppens

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of the cobas EGFR Mutation Test v2 in Europe.

The Journal of Molecular Diagnostics
2018-07 | Journal article
Source: Self-asserted source
Cleo Keppens
grade
Preferred source (of 2)‎

External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker Testing

The Journal of Molecular Diagnostics
2018-07 | Journal article
Contributors: Kelly Dufraing; Gert De Hertogh; Véronique Tack; Cleo Keppens; Elisabeth M.C. Dequeker; J. Han van Krieken
Source: check_circle
Crossref

External Quality Assessment schemes for gene mutation testing in oncology: Comparison of performance between FFPE-tissue and ctDNA in plasma

AMP Europe
2018-04-30 | Conference poster
Source: Self-asserted source
Cleo Keppens

A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer.

Oncotarget
2018-04-17 | Journal article
Source: Self-asserted source
Cleo Keppens

cobas® EGFR Mutation Test v2 in Plasma, the Fellowship of the RING trial

Medical Value Summit
2017-11 | Conference abstract
Source: Self-asserted source
Cleo Keppens

Kwaliteitscontrole op Europese schaal

Oncologie-Up-To-Date
2017-10 | Magazine article
Source: Self-asserted source
Cleo Keppens

Laboratory errors in the diagnostic process of RAS testing in Europe.

29th European congress of pathology.
2017-09-02 | Conference poster
Source: Self-asserted source
Cleo Keppens

Pre-analytical challenges during RAS testing: tissue quality and the estimation of tumour cell percentage.

29th European Congress of Pathology
2017-09-02 | Conference poster
Source: Self-asserted source
Cleo Keppens

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers' survey.

Virchows Archiv
2017-08 | Journal article
Source: Self-asserted source
Cleo Keppens

Results of the first European pilot external quality assessment scheme for the analysis of circulating tumour DNA.

LKI symposium Liquid Biopsies & Cancer
2017-08-28 | Conference poster
Source: Self-asserted source
Cleo Keppens

Inter-Laboratory Comparison of the Roche Cobas EGFR Mutation Test v2 in Plasma.

Journal of Thoracic Oncology
2016-12-04 | Conference paper
Source: Self-asserted source
Cleo Keppens

Error types in external quality assessment schemes and corrective actions to improve laboratory performance.

The XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology.
2016-09-25 | Conference poster
Source: Self-asserted source
Cleo Keppens

Three Rounds of External Quality Assessment in France to Evaluate the Performance of 28 Platforms for Multiparametric Molecular Testing in Metastatic Colorectal and Non-Small Cell Lung Cancer.

The Journal of Molecular Diagnostics
2016-03 | Journal article
Source: Self-asserted source
Cleo Keppens

Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.

Biochimica et Biophysica Acta
2016-01 | Journal article
Source: Self-asserted source
Cleo Keppens

Evaluation of a novel sample pre-treatment method for improved ELISA measurements in a hyperamyloidosis model of Alzheimer's Disease.

Alzheimer's & Dementia
2014-07-12 | Conference paper
Source: Self-asserted source
Cleo Keppens